Your browser doesn't support javascript.
loading
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
Villa, Diego; Hoster, Eva; Hermine, Olivier; Klapper, Wolfram; Szymczyk, Michal; Bosly, André; Unterhalt, Michael; Rimsza, Lisa M; Ramsower, Colleen A; Freeman, Ciara L; Scott, David W; Gerrie, Alina S; Savage, Kerry J; Sehn, Laurie H; Dreyling, Martin.
Afiliación
  • Villa D; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
  • Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Hermine O; Hôpital Necker, Assistance Publique Hôpitaux de Paris, University of Paris Descartes, Paris, France.
  • Klapper W; Department of Pathology, Hematopathology Section, University-Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
  • Szymczyk M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Bosly A; Centre Hospitalier Universitaire - Université Catholique de Louvain Mont-Godinne-Dinant, Yvoir, Belgium.
  • Unterhalt M; Medizinische Klinik III, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Rimsza LM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ; and.
  • Ramsower CA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ; and.
  • Freeman CL; H. Lee Moffitt Cancer Centre & Research Institute and Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Scott DW; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
  • Gerrie AS; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
  • Savage KJ; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
  • Sehn LH; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
  • Dreyling M; Medizinische Klinik III, Ludwig-Maximilians-Universität München, Munich, Germany.
Blood Adv ; 6(18): 5285-5294, 2022 09 27.
Article en En | MEDLINE | ID: mdl-35439293
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Canadá